Race to the Bottom’: Australia’s Weak Medical Device Laws Leave Patients Paralysed, Investigation Reveals
Vicki Kelly should be sipping cocktails on a cruise ship deck right now. Instead, the 69-year-old Victorian mother of three has spent the past 17
Vicki Kelly should be sipping cocktails on a cruise ship deck right now. Instead, the 69-year-old Victorian mother of three has spent the past 17 months in a hospital bed, paralysed from the waist down after a tiny pump implanted to treat her back pain triggered a catastrophic blood clot.
Her story is not an anomaly. It is the human cost of a regulatory system that critics describe as a "race to the bottom"—one where more than 150,000 medical device incidents require hospitalisation every year across Australia, according to federal government data from the Australian Institute of Health and Welfare.
The investigation, published by The Age and The Sydney Morning Herald, exposes gaping holes in the country's medical device oversight. While pharmaceutical drugs face rigorous testing before reaching patients, thousands of devices—from hip implants to spinal pumps—enter the market with minimal scrutiny.
A Catastrophic Injury
Kelly's ordeal began with what should have been a routine solution for chronic back pain. Doctors implanted a small, expensive pump designed to deliver medication directly to her spine. The device led to a blood clot that blocked a spinal cord artery.
"I thought, this is my time," Kelly said from her hospital bed, describing the retirement she had planned. "I just wanted to do some things for me. Everything has always been about everybody else."
Instead, she faces a nightmare. "I can't get up. I can't walk, I can't get myself out of bed," she said. "No one is telling me exactly what happened, what caused it. They are saying it is one in a million, and I don't believe that."
Her doctor delivered devastating news: the injury was catastrophic, something they had never encountered before. Yet Kelly remains haunted by questions that go beyond her own recovery. "Is this going to affect someone else? Is the pump going to play up again?"
Regulatory Gaps
The scale of the problem is staggering. More than 150,000 device-related incidents land Australians in hospital annually, yet the Therapeutic Goods Administration (TGA)—the federal regulator responsible for overseeing medical devices—operates with far less stringent requirements than its pharmaceutical counterpart.
Unlike new drugs, which must undergo years of clinical trials, many medical devices can be approved based on similarity to existing products. This "equivalence" pathway allows manufacturers to bypass extensive safety testing if they can demonstrate their device resembles one already on the market.
Health policy experts have long warned that this approach creates dangerous loopholes. Devices that might interact with human tissue in unpredictable ways—particularly implants like Kelly's pump—can reach patients without robust long-term safety data.
The investigation reveals a system struggling to keep pace with medical innovation. As devices become more complex, incorporating software, nanotechnology, and novel materials, the regulatory framework remains rooted in outdated assumptions about risk.
The Human Toll
Behind the statistics are stories like Kelly's—lives permanently altered by devices that were supposed to heal. The 150,000 annual hospitalisations represent not just numbers, but individuals facing additional surgeries, chronic pain, disability, and in some cases, death.
Patient advocates argue that the current system prioritises industry speed over public safety. While manufacturers can bring products to market quickly, patients who suffer harm face lengthy battles for compensation and answers.
Kelly's case highlights another critical gap: transparency. Seventeen months after her injury, she still lacks clear answers about what went wrong. The "one in a million" explanation offered by medical staff provides little comfort—and raises questions about whether such incidents are truly rare or simply underreported.
The investigation comes at a time when Australia's healthcare system faces mounting pressure. An ageing population means more people will require medical devices, from joint replacements to cardiac implants. Each represents a potential point of failure in a system that critics say is already stretched too thin.
Calls for Reform
The findings have intensified calls for regulatory overhaul. Health policy experts are demanding the TGA adopt more rigorous pre-market testing requirements, particularly for high-risk implantable devices. They also want better post-market surveillance to catch problems before they affect thousands of patients.
Some propose a mandatory registry system that tracks every implanted device and patient outcome—a model already used in several European countries. Such a system could have identified patterns in pump failures before Kelly's injury occurred.
For now, Kelly remains in hospital, her cruise ship dreams on indefinite hold. Her case has become a rallying point for patient safety advocates who argue that Australia's medical device laws need urgent strengthening.
The TGA has not yet responded to the investigation's findings. But with 150,000 Australians hospitalised each year due to device incidents, the pressure for change is mounting. Kelly's question—"Is this going to affect someone else?"—now hangs over every device approval decision the regulator makes.
